HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 2992945)

Published in J Neurochem on February 04, 2008

Authors

Stephanie zur Nedden1, Bettina Tomaselli, Gabriele Baier-Bitterlich

Author Affiliations

1: Division of Neurobiochemistry, Medical University of Innsbruck, Biocenter, Innsbruck, Austria.

Articles cited by this

Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A (1976) 21.06

International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev (2001) 9.90

Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol (1999) 9.32

Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem (1997) 7.67

HIF-1 and human disease: one highly involved factor. Genes Dev (2000) 5.41

The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci (2001) 4.17

Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J (1998) 3.63

Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ (2007) 3.55

Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63

Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem Pharmacol (2001) 2.31

Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci (2007) 2.24

A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem (1994) 2.03

Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc Natl Acad Sci U S A (2002) 1.88

Inosine reduces ischemic brain injury in rats. Stroke (2005) 1.83

Trophic effects of purines in neurons and glial cells. Prog Neurobiol (1999) 1.82

ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett (2000) 1.81

Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci (1999) 1.75

Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol (2002) 1.59

A2A adenosine receptors from rat striatum and rat pheochromocytoma PC12 cells: characterization with radioligand binding and by activation of adenylate cyclase. Mol Pharmacol (1992) 1.57

Brain adenosine concentration during hypoxia in rats. Am J Physiol (1981) 1.48

Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest (1997) 1.47

Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells. J Biol Chem (1999) 1.47

Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol Sci (1992) 1.38

Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci Lett (1982) 1.34

Membrane depolarization in PC-12 cells during hypoxia is regulated by an O2-sensitive K+ current. Am J Physiol (1996) 1.30

Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand (1991) 1.27

Extracellular adenosine, inosine, hypoxanthine, and xanthine in relation to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem (1987) 1.22

MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. Biochem Biophys Res Commun (2001) 1.20

Differential inhibition of nerve growth factor responses by purine analogues: correlation with inhibition of a nerve growth factor-activated protein kinase. J Cell Biol (1989) 1.19

Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages. J Leukoc Biol (2007) 1.16

Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 1.16

Nucleofection of primary neurons. Methods Enzymol (2006) 1.06

Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke (1999) 1.05

Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function. Blood (1998) 1.03

Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha. Mol Pharmacol (2001) 1.03

Axon outgrowth is regulated by an intracellular purine-sensitive mechanism in retinal ganglion cells. J Biol Chem (1998) 1.02

Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J Cell Physiol (2003) 1.02

Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv Pharmacol (1997) 1.00

Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity. Neurosci Biobehav Rev (1997) 1.00

Adenosine modulates hypoxia-induced responses in rat PC12 cells via the A2A receptor. J Physiol (1998) 0.96

Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci Lett (1998) 0.95

The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res (2006) 0.94

Differential vulnerability of cortical and cerebellar neurons in primary culture to oxygen glucose deprivation followed by reoxygenation. J Neurosci Res (2001) 0.94

Responding to hypoxia: lessons from a model cell line. Sci STKE (2002) 0.94

Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur J Pharmacol (1999) 0.93

Nerve growth factor employs multiple pathways to induce primary response genes in PC12 cells. Mol Biol Cell (1992) 0.93

Adaptive responses of vertebrate neurons to hypoxia. J Exp Biol (2002) 0.93

Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during chemical hypoxia. Brain Res (1999) 0.93

Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res (1990) 0.92

Signaling via A2A adenosine receptor in four PC12 cell clones. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.92

Adenosine inhibits cell division and promotes neurite extension in PC12 cells. J Cell Physiol (1984) 0.91

Inosine mediates the protective effect of adenosine in rat astrocyte cultures subjected to combined glucose-oxygen deprivation. J Neurochem (1996) 0.91

A purine-sensitive pathway regulates multiple genes involved in axon regeneration in goldfish retinal ganglion cells. J Neurosci (2000) 0.90

Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.89

Amino acid and purine release in rat brain following temporary middle cerebral artery occlusion. Neurochem Res (1994) 0.89

Neurite outgrowth in PC12 cells is enhanced by guanosine through both cAMP-dependent and -independent mechanisms. Neurosci Lett (1996) 0.88

Stimulation of expression for the adenosine A2A receptor gene by hypoxia in PC12 cells. A potential role in cell protection. J Biol Chem (1999) 0.88

Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain. J Neurochem (2007) 0.88

Plasticity of purine release during cerebral ischemia: clinical implications? J Cell Mol Med (2004) 0.87

Adenosine A1 receptors are associated with cerebellar granule cells. J Neurochem (1983) 0.87

Inhibition of adenosine kinase during oxygen-glucose deprivation in rat cortical neuronal cultures. Neurosci Lett (1998) 0.86

What can adenosine neuromodulation do for neuroprotection? Curr Drug Targets CNS Neurol Disord (2005) 0.86

Fate of cyclic nucleotides in PC12 cell cultures: uptake, metabolism, and effects of metabolites on nerve growth factor-induced neurite outgrowth. J Neurochem (1986) 0.86

Purine nucleosides support the neurite outgrowth of primary rat cerebellar granule cells after hypoxia. Eur J Cell Biol (2004) 0.85

Purine nucleoside-mediated protection of chemical hypoxia-induced neuronal injuries involves p42/44 MAPK activation. Neurochem Int (2005) 0.85

Calcineurin contributes to the enhancing effect of adenosine on nerve growth factor-induced neurite outgrowth via the decreased duration of p38 mitogen-activated protein kinase phosphorylation. J Pharmacol Sci (2004) 0.82

Release and actions of adenosine in the central nervous system. Pharm World Sci (1994) 0.78